• 1
    Lang TF, Keyak JH, Heitz MW, et al. Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. Bone. 1997; 21: 101108.
  • 2
    Black DM, Bouxsein ML, Marshall LM, et al. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using quantitative computed tomography. J Bone Miner Res. 2008; 23: 13261333.
  • 3
    Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006; 20: 24922506.
  • 4
    Duncan EL, Cardon LR, Sinsheimer JS, Wass JA, Brown MA. Site and gender specificity of inheritance of bone mineral density. J Bone Miner Res. 2003; 18: 15311538.
  • 5
    Kesavan C, Mohan S, Srivastava AK, et al. Identification of genetic loci that regulate bone adaptive response to mechanical loading in C57BL/6J and C3H/HeJ mice intercross. Bone. 2006; 39: 634643.
  • 6
    Turner CH, Roeder RK, Wieczorek A, Foroud T, Liu G, Peacock M. Variability in skeletal mass, structure, and biomechanical properties among inbred strains of rats. J Bone Miner Res. 2001; 16: 15321539.
  • 7
    Judex S, Garman R, Squire M, Donahue LR, Rubin C. Genetically based influences on the site-specific regulation of trabecular and cortical bone morphology. J Bone Miner Res. 2004; 19: 600606.
  • 8
    Bouxsein ML, Uchiyama T, Rosen CJ, et al. Mapping quantitative trait loci for vertebral trabecular bone volume fraction and microarchitecture in mice. J Bone Miner Res. 2004; 19: 587599.
  • 9
    Havill LM, Mahaney MC, Binkley TL, Specker BL. Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J Bone Miner Res. 2007; 22: 737746.
  • 10
    Wang X, Kammerer CM, Wheeler VW, Patrick AL, Bunker CH, Zmuda JM. Genetic and environmental determinants of volumetric and areal BMD in multi-generational families of African ancestry: the Tobago Family Health Study. J Bone Miner Res. 2007; 22: 527536.
  • 11
    Wang X, Kammerer CM, Wheeler VW, Patrick AL, Bunker CH, Zmuda JM. Pleiotropy and heterogeneity in the expression of bone strength-related phenotypes in extended pedigrees. J Bone Miner Res. 2007; 22: 17661772.
  • 12
    Orwoll E, Blank JB, Barrett-Connor E, et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study: a large observational study of the determinants of fracture in older men. Contemp Clin Trials. 2005; 26: 569585.
  • 13
    Blank JB, Cawthon PM, Carrion-Petersen ML, et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials. 2005; 26: 557568.
  • 14
    Marshall LM, Lang TF, Lambert LC, Zmuda JM, Ensrud KE, Orwoll ES. Dimensions and volumetric BMD of the proximal femur and their relation to age among older US men. J Bone Miner Res, 2006; 21: 11971206.
  • 15
    Li W, Sode M, Saeed I, Lang T. Automated registration of hip and spine for longitudinal QCT studies: integration with 3D densitometric and structural analysis. Bone. 2006; 38: 273279.
  • 16
    International HapMap Project. Nature. 2003; 426: 789796.
  • 17
    Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B. Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol. 2005; 28: 207219.
  • 18
    Zhao T, Chang LW, McLeod HL, Stormo GD. PromoLign: a database for upstream region analysis and SNPs. Hum Mutat. 2004; 23: 534539.
  • 19
    Conde L, Vaquerizas JM, Santoyo J, et al. PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res. 2004; 32: W242W248.
  • 20
    Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 2003; 164: 15671587.
  • 21
    Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38: 904909.
  • 22
    Subramaniam M, Gorny G, Johnsen SA, et al. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol. 2005; 25: 11911199.
  • 23
    Hefferan TE, Reinholz GG, Rickard DJ, et al. Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J Biol Chem. 2000; 275: 2025520259.
  • 24
    Bensamoun SF, Hawse JR, Subramaniam M, et al. TGFβ inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bone. 2006; 39: 12441251.
  • 25
    Sakamoto MK, Suzuki K, Takiya S, et al. Developmental profiles of phosphorylated and unphosphorylated CREBs in murine calvarial MC3T3-E1 cells. J Biochem. 1998; 123: 399407.
  • 26
    Vale-Cruz DS, Ma Q, Syme J, LuValle PA. Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression. Mech Dev. 2008; 125: 843856.
  • 27
    Reimold AM, Grusby MJ, Kosaras B, et al. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature. 1996; 379: 262265.
  • 28
    Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet. 2001; 27: 8488.
  • 29
    Luyten FP, Cunningham NS, Ma S, et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem. 1989; 264: 1337713380.
  • 30
    Matsumoto Y, Tanaka K, Hirata G, et al. Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol. 2002; 168: 58245831.
  • 31
    Nakagawa M, Kaneda T, Arakawa T, et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 2000; 473: 161164.
  • 32
    Niida S, Kaku M, Amano H, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med. 1999; 190: 293298.
  • 33
    Ren WP, Markel DC, Zhang R, et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials. 2006; 27: 51615169.
  • 34
    Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 2000; 141: 16671674.
  • 35
    Otomo H, Sakai A, Uchida S, et al. Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone. 2007; 40: 14941501.
  • 36
    Bassett JH, Williams GR. Critical role of the hypothalamic-pituitary-thyroid axis in bone. Bone. 2008; 43: 418426.
  • 37
    Hartmann C. A WNT canon orchestrating osteoblastogenesis. Trends Cell Biol. 2006; 16: 151158.
  • 38
    Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by WNT signaling. J Clin Invest. 2006; 116: 12021209.
  • 39
    Westendorf JJ, Kahler RA, Schroeder TM. WNT signaling in osteoblasts and bone diseases. Gene. 2004; 341: 1939.
  • 40
    Monaghan H, Bubb VJ, Sirimujalin R, Millward-Sadler SJ, Salter DM. Adenomatous polyposis coli (APC), beta-catenin, and cadherin are expressed in human bone and cartilage. Histopathology. 2001; 39: 611619.
  • 41
    Holmen SL, Zylstra CR, Mukherjee A, et al. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem. 2005; 280: 2116221168.
  • 42
    Wallis YL, Morton DG, McKeown CM, Macdonald F. Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet. 1999; 36: 1420.
  • 43
    Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA. 1995; 92: 30463050.
  • 44
    Ralston SH, Uitterlinden AG, Brandi ML, et al. Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med. 2006; 3: e90.
  • 45
    Ioannidis JP, Stavrou I, Trikalinos TA, et al. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res. 2002; 17: 20482060.
  • 46
    van Meurs JB, Trikalinos TA, Ralston SH, et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 2008; 299: 12771290.
  • 47
    Uitterlinden AG, Ralston SH, Brandi ML, et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006; 145: 255264.
  • 48
    Richards JB, Rivadeneira F, Inouye M, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet. 2008; 371: 15051512.
  • 49
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358: 23552365.
  • 50
    Weedon MN, Lango H, Lindgren CM, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet. 2008; 40: 575583.